People_

Dr Kate Simms

PhD

Honorary Senior Research Fellow
Sydney School of Public Health
Faculty of Medicine and Health
Lead, Cervical Cancer and HPV Stream
The Daffodil Centre

Email

kate.simms@sydney.edu.au

Websites

The Daffodil Centre

Biographical details

Dr Kate Simms is a Senior Research Fellow at the Daffodil Centre. Dr Simms currently holds a Career Development Fellowship from Cancer Institute, and is currently also funded by CISNET-cervical, a US-NIH funded grant involving a consortium of modellers who use comparative modelling to assess the impact of cervical cancer prevention in USA. Dr Simms’research has had significant policy impact: in 2014 she co-led the economic evaluation to inform Australia’s cervical screening renewal, which directly informed the government’s decision to switch from 2-yearly cytology to 5-yearly primary HPV testing. Dr Simmsled the modelled evaluation on the potential for cervical cancer elimination for 181 countries, in collaboration with the International Agency for Research on Cancer, and was one of the researchers involved in the Cervical Cancer Elimination Modelling Consortium that directly informed WHO cervical cancer elimination strategy. Dr Simms is currently involved in modelling a range of cervical cancer screening guidelines to directly inform WHO’s updated cervical cancer screening guidelines. She has also been involved evaluations across a range of other countries, including modelling to inform the impact of vaccine hesitancy in Japan, and modelling to determine the optimal screening strategy for women in Urban China.

Research interests

Dr Simms interests are in health economics and modelling of cervical cancer prevention strategies in low-and lower-middle income countries

Current projects

modelled evaluations to inform 2021 WHO cervical screening guidelines;
modelled evaluations to inform evaluations for US-NIH funded CISNET grant;
modelled evaluations to inform optimal screening in Guam and Yap.

Keywords

Cervical cancer, HPV vaccination, HPV screening, Modelling

Current research students

Project title	Research student
Cervical screening in women with Down syndrome	Sally BYATT
Evaluation of Effectiveness and Cost Effectiveness of HPV Vaccination Program in combination with Potential Cervical Cancer Screening and Treatment Strategies and Estimation of Timeframe towards Cervical Cancer Elimination in Myanmar	Tay Za Kyi Win WIN

Publications

By Type

Expand all

Journals

Qin, J., Marfel, M., Simms, K., Canfell, K., Maxwell, K., Saraiya, M., Palafox, N., Scarinci, I., Lu, E., Senkomago, V., Nguyen, D., et al (2024). Building Capacity for Cervical Cancer Prevention in U.S.-Affiliated Pacific Islands: The Pacific Against Cervical Cancer Project. Journal of Women's Health. [More Information]
Wee, H., Canfell, K., Chiu, H., Choi, K., Cox, B., Bhoo-Pathy, N., Simms, K., Hamashima, C., Shen, Q., Chua, B., et al (2024). Cancer screening programs in South-east Asia and Western Pacific. BMC Health Services Research, 24(1). [More Information]
Nickson, C., Smith, M., Feletto, E., Velentzis, L., Broun, K., Deij, S., Grogan, P., Hall, M., He, E., St John, D., Lew, J., Procopio, P., Simms, K., Worthington, J., Canfell, K., et al (2023). A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia. eLife, 12. [More Information]
Vallely, A., Saville, M., Badman, S., Gabuzzi, J., Bolnga, J., Mola, G., Kuk, J., Wai, M., Munnull, G., Garland, S., Simms, K., Canfell, K., et al (2022). Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT). The Lancet Global Health, 10(9), e1336-e1346. [More Information]
Kang, Y., Caruana, M., McLoughlin, K., Killen, J., Simms, K., Taylor, N., Frayling, I., Coupe, V., Boussioutas, A., Trainer, A., Ward, R., Canfell, K., et al (2022). The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome. Genetics in Medicine, 24(9), 1831-1846. [More Information]
Smith, M., Hall, M., Saville, M., Brotherton, J., Simms, K., Lew, J., Bateson, D., Skinner, R., Kelaher, M., Canfell, K. (2021). Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis. Cancer Epidemiology Biomarkers and Prevention, 30(2), 268-277. [More Information]
Hall, M., Smith, M., Simms, K., Barnabas, R., Murray, J., Canfell, K. (2021). Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control. International Journal of Cancer, 149(2), 297-306. [More Information]
Keane, A., Shi, J., Simms, K., Liu, Y., Lew, J., Mazariego, C., Yuill, S., Wu, R., Liu, Z., Zhao, F., Canfell, K., et al (2021). Health economic evaluation of primary human papillomavirus screening in urban populations in China. Cancer Epidemiology, 70, 101861. [More Information]
Kim, J., Simms, K., Killen, J., Smith, M., Burger, E., Sy, S., Regan, C., Canfell, K. (2021). Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLoS Medicine, 18(3), e1003534. [More Information]
Keane, A., Ng, C., Simms, K., Nguyen, D., Woo, Y., Saville, M., Canfell, K. (2021). The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support. International Journal of Cancer, 149(12), 1997-2009. [More Information]
Burger, E., de Kok, I., Groene, E., Killen, J., Canfell, K., Kulasingam, S., Kuntz, K., Matthijsse, S., Regan, C., Simms, K., Smith, M., et al (2020). Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis. Journal of the National Cancer Institute, 14(10), 1-9. [More Information]
Simms, K., Yuill, S., Killen, J., Smith, M., Kulasingam, S., de Kok, I., van Ballegooijen, M., Burger, E., Regan, C., Kim, J., Canfell, K. (2020). Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. Gynecologic Oncology, 158(3), 710-718. [More Information]
Brisson, M., Kim, J., Canfell, K., Drolet, M., Gingras, G., Burger, E., Martin, D., Simms, K., Bénard, É., Boily, M., Keane, A., Caruana, M., Nguyen, D., Smith, M., et al (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 575-590. [More Information]
Simms, K., Hanley, S., Smith, M., Keane, A., Canfell, K. (2020). Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. The Lancet Public Health, 5(4), e223-e234. [More Information]
Canfell, K., Kim, J., Brisson, M., Keane, A., Simms, K., Caruana, M., Burger, E., Martin, D., Nguyen, D., Bénard, É., Smith, M., et al (2020). Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 591-603. [More Information]
Burger, E., Smith, M., Killen, J., Sy, S., Simms, K., Canfell, K., Kim, J. (2020). Projected time to elimination of cervical cancer in the USA: a comparative modelling study. The Lancet Public Health, 5(4), e213-e222. [More Information]
de Kok, I., Burger, E., Naber, S., Canfell, K., Killen, J., Simms, K., Kulasingam, S., Groene, E., Sy, S., Kim, J., et al (2020). The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology. Medical Decision Making, 40(4), 474-482. [More Information]
Hall, M., Smith, M., Simms, K., Barnabas, R., Canfell, K., Murray, J. (2020). The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study. PloS One, 15(5), e0231388. [More Information]
Kang, Y., Killen, J., Caruana, M., Simms, K., Taylor, N., Frayling, I., Snowsill, T., Huxley, N., Coupe, V., Hughes, S., Ward, R., Canfell, K., et al (2020). The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome. Medical Journal of Australia, 212(2), 72-81. [More Information]
Simms, K., Smith, M., Caruana, M., Canfell, K. (2019). An HBV booster shot at age 10 could be cost-saving: but is it too soon to tell? International Journal of Infectious Diseases, 78, 128-129. [More Information]
Lew, J., Feletto, E., Wade, S., Caruana, M., Kang, Y., Nickson, C., Simms, K., Procopio, P., Taylor, N., Worthington, J., Smith, D., Canfell, K. (2019). Benefits, harms and cost-effectiveness of cancer screening in Australia: An overview of modelling estimates. Public Health Research and Practice, 29(2), 1-11. [More Information]
Hall, M., Smith, M., Brotherton, J., Simms, K., Canfell, K. (2019). Cancer elimination thresholds: one size does not fit all - Authors' reply. The Lancet Public Health, 4(2), e87. [More Information]
Liu, Y., Keane, A., Simms, K., Lew, J., Shi, J., Mazariego, C., Yuill, S., Jeronimo, J., Qiao, Y., Canfell, K. (2019). Development and application of a framework to estimate health care costs in China: The cervical cancer example. PloS One, 14(10), 1-13. [More Information]
Canfell, K., Kim, J., Kulasingam, S., Berkhof, J., Barnabas, R., Bogaards, J., Campos, N., Jennett, C., Sharma, M., Simms, K., Smith, M., et al (2019). HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Research, 8, 100184. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. The Lancet Oncology, 20(3), 394-407. [More Information]
Nguyen, D., Hughes, S., Egger, S., Lamontagne, D., Simms, K., Castle, P., Canfell, K. (2019). Risk of childhood mortality associated with death of a mother in low-and-middle-income countries: A systematic review and meta-analysis. BMC Public Health, 19, 1-21. [More Information]
Thi Nguyen, D., Simms, K., Vu Nguyen, H., Van Tran, T., Nguyen, N., Lamontagne, D., Castle, P., Canfell, K. (2019). The burden of cervical cancer in Vietnam: Synthesis of the evidence. Cancer Epidemiology, 59, 83-103. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Brotherton, J., Saville, M., Frazer, I., Canfell, K. (2019). The projected timeframe until cervical cancer elimination in Australia: a modelling study. The Lancet Public Health, 4(1), e19-e27. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Towards global elimination of cervical cancer in all groups of women - Authors' reply. The Lancet Oncology, 20(5), e239. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Saville, M., Canfell, K. (2018). Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia. PloS One, 13(2), 1-19. [More Information]
Velentzis, L., Caruana, M., Simms, K., Lew, J., Shi, J., Saville, M., Smith, M., Lord, S., Tan, J., Bateson, D., Canfell, K., et al (2017). How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International Journal of Cancer, 141(12), 2410-2422. [More Information]
Simms, K., Hall, M., Smith, M., Lew, J., Hughes, S., Yuill, S., Hammond, I., Saville, A., Canfell, K. (2017). Optimal management strategies for primary HPV testing for cervical screening: Cost-effectiveness evaluation for the national cervical screening program in Australia. PloS One, 12(1), 1-23. [More Information]
Lew, J., Simms, K., Smith, M., Hall, M., Kang, Y., Xu, X., Caruana, M., Velentzis, L., Bessell, T., Saville, A., Canfell, K., et al (2017). Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. The Lancet Public Health, 2(2), e96-e107. [More Information]
Simms, K., Laprise, J., Smith, M., Lew, J., Caruana, M., Brisson, M., Canfell, K. (2016). Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. The Lancet Public Health, 1(2), e66-e75. [More Information]
Lew, J., Simms, K., Smith, M., Lewis, H., Neal, H., Canfell, K. (2016). Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand. PloS One, 11(5), 1-21. [More Information]
Smith, M., Lew, J., Simms, K., Canfell, K. (2016). Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program. Medical Journal of Australia, 204(5), 194.e1-194.e9. [More Information]
Smith, M., Gertig, D., Hall, M., Simms, K., Lew, J., Malloy, M., Saville, M., Canfell, K. (2016). Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use. BMC Health Services Research, 16(1), 1-14. [More Information]

show 34 more

Magazine / Newspaper Articles

Canfell, K., Hall, M., Simms, K., Smith, M., Saville, M. (2018). Australia on-track to be the first country to achieve cervical cancer elimination. HPV World.

Report

Smith, M., Hall, M., Simms, K., Killen, J., Sherrah, M., O’Farrell, X., Canfell, K., Grogan, P. (2020). Modelled analysis of hypothetical impacts of COVID-19 related disruptions to the National Cervical Screening Program.

By Year

Expand all

2024

Qin, J., Marfel, M., Simms, K., Canfell, K., Maxwell, K., Saraiya, M., Palafox, N., Scarinci, I., Lu, E., Senkomago, V., Nguyen, D., et al (2024). Building Capacity for Cervical Cancer Prevention in U.S.-Affiliated Pacific Islands: The Pacific Against Cervical Cancer Project. Journal of Women's Health. [More Information]
Wee, H., Canfell, K., Chiu, H., Choi, K., Cox, B., Bhoo-Pathy, N., Simms, K., Hamashima, C., Shen, Q., Chua, B., et al (2024). Cancer screening programs in South-east Asia and Western Pacific. BMC Health Services Research, 24(1). [More Information]

2023

Nickson, C., Smith, M., Feletto, E., Velentzis, L., Broun, K., Deij, S., Grogan, P., Hall, M., He, E., St John, D., Lew, J., Procopio, P., Simms, K., Worthington, J., Canfell, K., et al (2023). A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia. eLife, 12. [More Information]

2022

Vallely, A., Saville, M., Badman, S., Gabuzzi, J., Bolnga, J., Mola, G., Kuk, J., Wai, M., Munnull, G., Garland, S., Simms, K., Canfell, K., et al (2022). Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT). The Lancet Global Health, 10(9), e1336-e1346. [More Information]
Kang, Y., Caruana, M., McLoughlin, K., Killen, J., Simms, K., Taylor, N., Frayling, I., Coupe, V., Boussioutas, A., Trainer, A., Ward, R., Canfell, K., et al (2022). The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome. Genetics in Medicine, 24(9), 1831-1846. [More Information]

2021

Smith, M., Hall, M., Saville, M., Brotherton, J., Simms, K., Lew, J., Bateson, D., Skinner, R., Kelaher, M., Canfell, K. (2021). Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis. Cancer Epidemiology Biomarkers and Prevention, 30(2), 268-277. [More Information]
Hall, M., Smith, M., Simms, K., Barnabas, R., Murray, J., Canfell, K. (2021). Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control. International Journal of Cancer, 149(2), 297-306. [More Information]
Keane, A., Shi, J., Simms, K., Liu, Y., Lew, J., Mazariego, C., Yuill, S., Wu, R., Liu, Z., Zhao, F., Canfell, K., et al (2021). Health economic evaluation of primary human papillomavirus screening in urban populations in China. Cancer Epidemiology, 70, 101861. [More Information]
Kim, J., Simms, K., Killen, J., Smith, M., Burger, E., Sy, S., Regan, C., Canfell, K. (2021). Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLoS Medicine, 18(3), e1003534. [More Information]
Keane, A., Ng, C., Simms, K., Nguyen, D., Woo, Y., Saville, M., Canfell, K. (2021). The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support. International Journal of Cancer, 149(12), 1997-2009. [More Information]

show 2 more

2020

Burger, E., de Kok, I., Groene, E., Killen, J., Canfell, K., Kulasingam, S., Kuntz, K., Matthijsse, S., Regan, C., Simms, K., Smith, M., et al (2020). Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis. Journal of the National Cancer Institute, 14(10), 1-9. [More Information]
Simms, K., Yuill, S., Killen, J., Smith, M., Kulasingam, S., de Kok, I., van Ballegooijen, M., Burger, E., Regan, C., Kim, J., Canfell, K. (2020). Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. Gynecologic Oncology, 158(3), 710-718. [More Information]
Brisson, M., Kim, J., Canfell, K., Drolet, M., Gingras, G., Burger, E., Martin, D., Simms, K., Bénard, É., Boily, M., Keane, A., Caruana, M., Nguyen, D., Smith, M., et al (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 575-590. [More Information]
Simms, K., Hanley, S., Smith, M., Keane, A., Canfell, K. (2020). Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. The Lancet Public Health, 5(4), e223-e234. [More Information]
Smith, M., Hall, M., Simms, K., Killen, J., Sherrah, M., O’Farrell, X., Canfell, K., Grogan, P. (2020). Modelled analysis of hypothetical impacts of COVID-19 related disruptions to the National Cervical Screening Program.
Canfell, K., Kim, J., Brisson, M., Keane, A., Simms, K., Caruana, M., Burger, E., Martin, D., Nguyen, D., Bénard, É., Smith, M., et al (2020). Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 591-603. [More Information]
Burger, E., Smith, M., Killen, J., Sy, S., Simms, K., Canfell, K., Kim, J. (2020). Projected time to elimination of cervical cancer in the USA: a comparative modelling study. The Lancet Public Health, 5(4), e213-e222. [More Information]
de Kok, I., Burger, E., Naber, S., Canfell, K., Killen, J., Simms, K., Kulasingam, S., Groene, E., Sy, S., Kim, J., et al (2020). The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology. Medical Decision Making, 40(4), 474-482. [More Information]
Hall, M., Smith, M., Simms, K., Barnabas, R., Canfell, K., Murray, J. (2020). The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study. PloS One, 15(5), e0231388. [More Information]
Kang, Y., Killen, J., Caruana, M., Simms, K., Taylor, N., Frayling, I., Snowsill, T., Huxley, N., Coupe, V., Hughes, S., Ward, R., Canfell, K., et al (2020). The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome. Medical Journal of Australia, 212(2), 72-81. [More Information]

show 7 more

2019

Simms, K., Smith, M., Caruana, M., Canfell, K. (2019). An HBV booster shot at age 10 could be cost-saving: but is it too soon to tell? International Journal of Infectious Diseases, 78, 128-129. [More Information]
Lew, J., Feletto, E., Wade, S., Caruana, M., Kang, Y., Nickson, C., Simms, K., Procopio, P., Taylor, N., Worthington, J., Smith, D., Canfell, K. (2019). Benefits, harms and cost-effectiveness of cancer screening in Australia: An overview of modelling estimates. Public Health Research and Practice, 29(2), 1-11. [More Information]
Hall, M., Smith, M., Brotherton, J., Simms, K., Canfell, K. (2019). Cancer elimination thresholds: one size does not fit all - Authors' reply. The Lancet Public Health, 4(2), e87. [More Information]
Liu, Y., Keane, A., Simms, K., Lew, J., Shi, J., Mazariego, C., Yuill, S., Jeronimo, J., Qiao, Y., Canfell, K. (2019). Development and application of a framework to estimate health care costs in China: The cervical cancer example. PloS One, 14(10), 1-13. [More Information]
Canfell, K., Kim, J., Kulasingam, S., Berkhof, J., Barnabas, R., Bogaards, J., Campos, N., Jennett, C., Sharma, M., Simms, K., Smith, M., et al (2019). HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Research, 8, 100184. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. The Lancet Oncology, 20(3), 394-407. [More Information]
Nguyen, D., Hughes, S., Egger, S., Lamontagne, D., Simms, K., Castle, P., Canfell, K. (2019). Risk of childhood mortality associated with death of a mother in low-and-middle-income countries: A systematic review and meta-analysis. BMC Public Health, 19, 1-21. [More Information]
Thi Nguyen, D., Simms, K., Vu Nguyen, H., Van Tran, T., Nguyen, N., Lamontagne, D., Castle, P., Canfell, K. (2019). The burden of cervical cancer in Vietnam: Synthesis of the evidence. Cancer Epidemiology, 59, 83-103. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Brotherton, J., Saville, M., Frazer, I., Canfell, K. (2019). The projected timeframe until cervical cancer elimination in Australia: a modelling study. The Lancet Public Health, 4(1), e19-e27. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Towards global elimination of cervical cancer in all groups of women - Authors' reply. The Lancet Oncology, 20(5), e239. [More Information]

show 7 more

2018

Canfell, K., Hall, M., Simms, K., Smith, M., Saville, M. (2018). Australia on-track to be the first country to achieve cervical cancer elimination. HPV World.
Hall, M., Simms, K., Lew, J., Smith, M., Saville, M., Canfell, K. (2018). Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia. PloS One, 13(2), 1-19. [More Information]

2017

Velentzis, L., Caruana, M., Simms, K., Lew, J., Shi, J., Saville, M., Smith, M., Lord, S., Tan, J., Bateson, D., Canfell, K., et al (2017). How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International Journal of Cancer, 141(12), 2410-2422. [More Information]
Simms, K., Hall, M., Smith, M., Lew, J., Hughes, S., Yuill, S., Hammond, I., Saville, A., Canfell, K. (2017). Optimal management strategies for primary HPV testing for cervical screening: Cost-effectiveness evaluation for the national cervical screening program in Australia. PloS One, 12(1), 1-23. [More Information]
Lew, J., Simms, K., Smith, M., Hall, M., Kang, Y., Xu, X., Caruana, M., Velentzis, L., Bessell, T., Saville, A., Canfell, K., et al (2017). Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. The Lancet Public Health, 2(2), e96-e107. [More Information]

2016

Simms, K., Laprise, J., Smith, M., Lew, J., Caruana, M., Brisson, M., Canfell, K. (2016). Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. The Lancet Public Health, 1(2), e66-e75. [More Information]
Lew, J., Simms, K., Smith, M., Lewis, H., Neal, H., Canfell, K. (2016). Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand. PloS One, 11(5), 1-21. [More Information]
Smith, M., Lew, J., Simms, K., Canfell, K. (2016). Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program. Medical Journal of Australia, 204(5), 194.e1-194.e9. [More Information]
Smith, M., Gertig, D., Hall, M., Simms, K., Lew, J., Malloy, M., Saville, M., Canfell, K. (2016). Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use. BMC Health Services Research, 16(1), 1-14. [More Information]

show 1 more

Selected Grants

2020

Evaluating Novel Interventions To Facilitate Cervical Cancer Elimination Across Low and-Middle Income Countries And High Income Countries: A Modelled Evaluation, Simms K, Cancer Institute NSW/Career Development Fellowship

2017

Centre for Research Excellence in Cervical Cancer Control (C4), Canfell K, Brotherton J, Saville M, Castle P, Kaldor J, Garland S, Kelaher M, Guy R, Vallely A, Simms K, National Health and Medical Research Council (NHMRC)/Centres of Research Excellence